Page last updated: 2024-11-02

pioglitazone and Infections, Pseudomonas

pioglitazone has been researched along with Infections, Pseudomonas in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bedi, B1
Lin, KC1
Maurice, NM1
Yuan, Z1
Bijli, K1
Koval, M1
Hart, CM1
Goldberg, JB1
Stecenko, A1
Sadikot, RT1

Other Studies

1 other study available for pioglitazone and Infections, Pseudomonas

ArticleYear
UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.
    Clinical science (London, England : 1979), 2020, 07-31, Volume: 134, Issue:14

    Topics: A549 Cells; Aryldialkylphosphatase; beta-Defensins; Cystic Fibrosis; Endoplasmic Reticulum Stress; E

2020